Rational Identification of Novel Antibody‐Drug Conjugate with High Bystander Killing Effect against Heterogeneous Tumors

Yu Guo(Zhejiang Institute of Mechanical and Electrical Engineering), Xiaowu Dong(Second Affiliated Hospital of Zhejiang University), Luo Fang(Chinese Academy of Sciences), Zheyuan Shen(Second Affiliated Hospital of Zhejiang University), Yi Song(Institute of Mechanics), Jianpeng Sheng(Zhejiang Cancer Hospital), Jialiang Lu(Zhejiang Institute of Mechanical and Electrical Engineering), Zhan Zhou(Zhejiang Lab), Qiuqiu Shi(Zhejiang Institute of Mechanical and Electrical Engineering), Jinxin Che(Pharmaceutical Biotechnology (Czechia)), Lu Yang(Zhejiang Chinese Medical University), Wenbin Zhao(Zhejiang Lab), Mingfei Wu(Zhejiang University), Weihao Zhuang(Zhejiang Institute of Mechanical and Electrical Engineering), Liteng Shen(Zhejiang Lab), Yueping Qiu(Zhejiang University)
Advanced Science
January 25, 2024
10.1002/advs.202306309
Cited by 34

Related Papers

Majorbio Cloud: A one‐stop, comprehensive bioinformatic platform for multiomics analyses
|iMeta|2022|857
Dual detoxification and inflammatory regulation by ceria nanozymes for drug-induced liver injury therapy
|Nano Today|2020|145
Ultrasmall Ruthenium Nanoparticles with Boosted Antioxidant Activity Upregulate Regulatory T Cells for Highly Efficient Liver Injury Therapy
|Small|2022|82
ADCdb: the database of antibody–drug conjugates
|Nucleic Acids Research|2023|69
Metabolic linkages between indoor negative air ions, particulate matter and cardiorespiratory function: A randomized, double-blind crossover study among children
|Environment International|2020|67